HomePPGN • SWX
add
Polypeptide Group AG
Previous close
CHF 24.40
Day range
CHF 24.25 - CHF 25.75
Year range
CHF 13.22 - CHF 32.70
Market cap
851.82M CHF
Avg Volume
65.57K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 112.43M | 11.45% |
Operating expense | 15.21M | 44.05% |
Net income | 2.68M | 165.66% |
Net profit margin | 2.39 | 159.01% |
Earnings per share | — | — |
EBITDA | 21.16M | 174.69% |
Effective tax rate | 51.17% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 74.59M | 9.24% |
Total assets | 825.96M | 9.17% |
Total liabilities | 485.36M | 21.54% |
Total equity | 340.60M | — |
Shares outstanding | 32.98M | — |
Price to book | 2.36 | — |
Return on assets | 3.39% | — |
Return on capital | 5.95% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.68M | 165.66% |
Cash from operations | 13.93M | -68.68% |
Cash from investing | -30.45M | -3.58% |
Cash from financing | 13.31M | 304.36% |
Net change in cash | -1.05M | -110.64% |
Free cash flow | -17.55M | 22.54% |
About
Founded
1952
Headquarters
Website
Employees
1,395
